Immix Biopharma, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| IMMX | IAM | INBX | VRXA | MBX | IMM.L | |
|---|---|---|---|---|---|---|
| Market cap | 660.74M | 635.17M | 1.28B | 134.34M | 2.53B | 21.88M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -8.4 | — | -9.9 | — | -13.2 | 0.0 |
| Price/book | 2.5 | -1.4 | -24.1 | -0.7 | 6.1 | 11.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +163.04% | −29.14% | +7.12% | −90.96% | +112.13% | −69.00% |
| Today | +3.37% | −0.67% | +7.01% | −4.04% | −4.58% | +7.50% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All IMMX news ›MIMEDX announces $25M patent license agreement
MiMedx settles patent dispute with a wound care rival in a $25M licensing deal. - MiMedx Group (MDXG) on Wednesday said it has entered into a license agreement with a wound care competitor that resolves allegations of infringement of…
INmune Bio prices $4.5M registered direct offering and private placement
INmune Bio to raise $4.5M through a stock and warrants offering, with closing expected Oct. 29. - INmune Bio (INMB) said on Wednesday it agreed to sell 3M common shares and issue warrants for up to 3M additional shares to an institutional…
Immix Biopharma, Inc. (NASDAQ:IMMX) Stock Has Average Target Price of $24.29 According to Analysts
Posted by Danessa Lincoln on Oct 27th, 2026 View Our Latest Stock Report on Immix Biopharma Shares of IMMX opened at $8.06 on Tuesday. The business has a 50-day simple moving average of $11.37 and a two-hundred day simple moving average of…
MiMedx Group (MDXG) Set to Release Earnings on Wednesday
Posted by Tristan Rich on Oct 26th, 2026 Shares of MDXG stock opened at $3.91 on Monday. MiMedx Group has a 12 month low of $3.03 and a 12 month high of $7.97. The firm has a market cap of $569.92 million, a PE ratio of 97.77 and a beta of…
IMUNON To Sell ThermoDox Rights To VoxelDox For Glioblastoma Multiforme
IMUNON, Inc. (IMNN) said Wednesday it agreed to sell its rights to ThermoDox to VoxelDox Therapeutics in exchange for an equity stake, potential milestone payments and royalties. Upon completion of VoxelDox's financing, IMUNON will receive…
Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock
LOS ANGELES, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. ('ImmixBio”, 'Company”, 'we” or 'us” or 'IMMX”), a global leader in relapsed/refractory AL Amyloidosis, today announced the pricing of an underwritten registered…
ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results
--ImmuCell Corporation, an animal health biologics company that develops, manufactures and markets products to improve calf health and productivity, today announced preliminary, unaudited sales results for the third quarter of 2026..…
Stifel initiates coverage of Immatics with Buy rating, $15 price target
Stifel initiated coverage on Immatics's stock with a rating of Buy and a price target of $15.00. The price target implies an upside of 119.6% from the Oct 13 close of $6.83. Positive Clinical Trial Outlook: Immatics is advancing its Phase…
More from 1 other outlet
AmeraMex International, Inc. (AMMX) Books $1.4M Orders, 5-Year Lease
TradingView AmeraMex International, Inc. (AMMX) Books $1.4M Orders, 5-Year Lease AmeraMex International, Inc. reported $1.4M in new orders, including a five-year lease-to-purchase agreement and multiple equipment sales across the
ImmuCell Reports 46% Increase in Third-Quarter 2026 Sales
ImmuCell (ICCC) reported preliminary, unaudited total sales of $8.0 million for the three months ended September 30, 2026, up 46.0% from the prior-year quarter. For the first nine months of 2026, total sales were $25.6 million, an increase…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- seekingalpha.com4
- quiverquant.com3
- themarketsdaily.com3
- gurufocus.com2
- marketbeat.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 20 articles, not a forecast.